首页> 外文期刊>Clinical and experimental allergy : >Impaired macrophage phagocytosis in non-eosinophilic asthma
【24h】

Impaired macrophage phagocytosis in non-eosinophilic asthma

机译:非嗜酸性哮喘中巨噬细胞吞噬功能受损

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Many patients with non-eosinophilic asthma have increased numbers of neutrophils in the airways. The explanation for this chronic inflammation remains unclear, but may result from an impaired ability of alveolar macrophages to phagocytose apoptotic cells (a process termed 'efferocytosis'), as we have shown in chronic obstructive pulmonary disease (COPD). Objectives: To examine induced sputum as a non-invasive technique to characterize efferocytosis in chronic lung diseases and to compare efferocytosis in patients with non-eosinophilic asthma, eosinophilic asthma and COPD. Methods: Participants with stable asthma (20 with eosinophilic and 30 with non-eosinophilic) and COPD (n = 11) underwent clinical assessment including allergy skin tests, saline challenge and sputum induction. Sputum cells were dispersed using dithiothreitol and resuspended in culture medium. Efferocytosis of apoptotic bronchial epithelial cells by sputum-derived macrophages was determined using flow cytometry. Results: There were no significant differences in efferocytosis between paired sputum and bronchoalveolar lavage macrophages from three subjects. Efferocytosis was significantly impaired in patients with non-eosinophilic asthma [mean (SD) 0.95 (0.24)] compared with eosinophilic asthma [1.17 (0.19)] and to a similar degree as patients with COPD [1.04 (0.16)]. Sputum neutrophils were significantly higher in patients with COPD and non-eosinophilic asthma compared with eosinophilic asthma. Conclusion and Clinical Relevance: Induced sputum provides a reliable and non-invasive method for studying macrophage efferocytosis in chronic lung disease. Macrophage efferocytosis is impaired in non-eosinophilic asthma to a similar degree as that in COPD and may explain the persistent airway neutrophilia and chronic inflammation that characterizes this asthma subtype.
机译:背景:许多非嗜酸性哮喘患者的气道中性粒细胞数量增加。关于这种慢性炎症的解释尚不清楚,但可能是由于肺泡巨噬细胞吞噬细胞凋亡细胞的能力受损(这一过程称为“胞吞作用”),正如我们在慢性阻塞性肺疾病(COPD)中所显示的那样。目的:探讨诱导痰作为一种非侵入性技术,以表征慢性肺部疾病的胞吞作用,并比较非嗜酸性哮喘,嗜酸性哮喘和COPD患者的胞吞作用。方法:对患有稳定哮喘(20例嗜酸性粒细胞和30例非嗜酸粒细胞)和COPD(n = 11)的参与者进行临床评估,包括过敏性皮肤试验,盐水刺激和痰诱导。用二硫苏糖醇分散痰细胞并重悬于培养基中。使用流式细胞仪测定痰衍生的巨噬细胞对凋亡性支气管上皮细胞的泡腾作用。结果:三名受试者的配对痰和支气管肺泡灌洗巨噬细胞之间的胞吐作用没有显着差异。与嗜酸性哮喘[1.17(0.19)]相比,非嗜酸性哮喘[平均(SD)0.95(0.24)]患者的红细胞增多症明显受损,其程度与COPD患者[1.04(0.16)]相似。与嗜酸性哮喘相比,COPD和非嗜酸性哮喘患者中的痰中性粒细胞明显更高。结论和临床意义:诱导痰为研究慢性肺疾病中巨噬细胞的放血提供了可靠且非侵入性的方法。非嗜酸性哮喘中巨噬细胞的红细胞增多症的损害程度与COPD相似,并且可以解释这种哮喘亚型所特有的持续气道中性粒细胞增多和慢性炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号